Ifenprodil (Algernon Pharmaceuticals)

艾芬地尔(Algernon Pharmaceuticals)

Report date: 2026/01/26 20:01:04

Base Information

Drug NameIfenprodil (Algernon Pharmaceuticals)
Drug Alias NameNP-120
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 antagonists
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsCoughIdiopathic Pulmonary FibrosisCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaPhilippines +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlgernon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoughIdiopathic Pulmonary Fibrosis
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A